Form D · Biotechnology

VELOMEDIX, INC.

Menlo Park, CA · CIK 0001445296

Offering snapshot reported Dec 27, 2011 · SEC filing

Reported sold
$9.29M
Offering amount: $10.7M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 16, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 27, 2011Initial$9,291,198No comparison17SEC filing
Nov 8, 2011Amendment$5,300,000$300,000vs Nov 16, 201015SEC filing
Nov 16, 2010Amendment$5,000,000$745,230vs Oct 27, 201015SEC filing
Oct 27, 2010Initial$4,254,770No comparison2SEC filing
Nov 9, 2009Initial$3,500,001No comparison1SEC filing
Sep 11, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-170716
The actual total offering amount: $10,696,885.31; The actual amount sold: $9,291,198.41

Source: Form D, filed Dec 27, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Burnett Director
Andrew Cleeland Director
John Dean Director, Executive
Jim Dennis Director
Marc Galletti Director
Jeff Gold Director, Executive
Ken Ludlum Director
J. Casey Mc Glynn Executive
Casey Mc Glynn Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1455 Adams Drive Suite 1016
Menlo Park, CA, 94025